Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Jun 12, 2026

Viability Assays for Cells in Culture

Viability Assays for Cells in Culture

Published on: January 20, 2014

Checkpoint bypass and cell viability.

Jon H Chung¹, Yonggang Zhang, Fred Bunz

¹Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Cell Cycle (Georgetown, Tex.)

|May 28, 2010

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Dynamic Modulation of IRE1α-XBP1 Signaling by Adenovirus.

Pathogens (Basel, Switzerland)·2025

Same author

Robust p53 phenotypes and prospective downstream targets in telomerase-immortalized human cells.

Oncotarget·2025

Same author

Dynamic modulation of IRE1α-XBP1 signaling by adenovirus.

bioRxiv : the preprint server for biology·2024

Same author

Effect of Ultrahigh Dose Rate on Biomolecular Radiation Damage.

Radiation research·2024

Same author

Passengers, drivers, and "goners".

International journal of cancer·2024

Same author

Interferons in Colorectal Cancer Pathogenesis and Therapy.

Diseases & research·2024

Cancer cells with disabled checkpoints can survive DNA damage, challenging the assumption that checkpoint control dictates sensitivity. This suggests inherent cellular survival mechanisms may be independent of checkpoint pathways.

Area of Science:

Cell Biology
Genetics
Cancer Research

Background:

DNA damage halts cell growth by impeding DNA replication and chromosome segregation.
Cellular checkpoints normally regulate these processes, preventing damaged cells from progressing.
Tumors often disable checkpoints, allowing damaged cells to divide, which is linked to therapy efficacy.

Purpose of the Study:

To investigate if cancer cells that bypass checkpoints are always more sensitive to DNA damage than normal cells.
To explore the relationship between checkpoint proficiency and cellular survival following DNA damage.

Main Methods:

Analysis of checkpoint-proficient normal cells and checkpoint-deficient cancer cells.
Assessment of cellular responses to DNA-damaging agents.

More Related Videos

Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis

Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis

Published on: February 16, 2015

An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity

An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity

Published on: May 12, 2020

Related Experiment Videos

Last Updated: Jun 12, 2026

Viability Assays for Cells in Culture

Viability Assays for Cells in Culture

Published on: January 20, 2014

Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis

Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis

Published on: February 16, 2015

An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity

An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity

Published on: May 12, 2020

Evaluation of cell survival and proliferation after DNA damage induction.

Main Results:

Evidence suggests that the survival of damaged human cells can be independent of checkpoint control.
Checkpoint bypass in cancer cells does not invariably lead to greater sensitivity to DNA damage compared to normal cells.
Inherent cellular survival mechanisms may play a significant role.

Conclusions:

Cellular survival following DNA damage is not solely dependent on checkpoint function.
Checkpoint deficiency in cancer cells does not guarantee increased sensitivity to DNA-damaging therapies.
Further research is needed to understand the mechanisms of inherent DNA damage resistance.